Page 316 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 316
Autoimmune and Hepato Biliary Disease
P1137 INTEGRATED EFFICACY SUMMARY FOR OBETICHOLIC
ACID IN SUBJECTS WITH PRIMARY BILIARY CIRRHOSIS
Pietro Invernizzi*, Rich Pencek, Tonya Marmon, Leigh MacConell,
David Shapiro, Italy
P1138 LONG-TERM OUTCOME OF PATIENTS WITH AUTOIMMUNE
HEPATITIS RECEIVING MYCOPHENOLATE MOFETIL
(MMF) AS FIRST LINE TREATMENT
Kalliopi Zachou*, Nikolaos Gatselis, Stella Gabeta, Asterios Saitis,
George Koukoulis, George N. Dalekos, Greece
P1139 TESTOSTERONE SUPPRESSES HEPATIC INFLAMMATION
BY THE DOWN-REGULATION OF IL-17, CXCL-9 AND CXCL-
10 IN A MOUSE MODEL OF EXPERIMENTAL CHOLANGITIS
Dorothee Schwinge*, Antonella Carambia, Alexander Quaas, Till Krech,
Claudia Wegscheid, Gisa Tiegs, Immo Prinz, Ansgar W. Lohse,
Johannes Herkel, Christoph Schramm, Germany
P1140 NGM282 DEMONSTRATES POTENT ANTIFIBROTIC
ACTIVITY IN A MOUSE MODEL OF SEVERE CHOLESTATIC
ePOSTERS FIBROSIS
Jian Luo*, Brian Ko, Carmen To, Lei Ling, Stephen Rossi, Alex DePaoli,
Hui Tian, The United States
P1141 POST-TRANSLATIONAL REGULATION OF POLYCYSTIN
2 (PC2) EXPRESSION AS A NOVEL MECHANISM OF
CHOLANGIOCYTE REACTION TO BILIARY DAMAGE AND
REPAIR
Carlo Spirli*, Ambra Villani, Carola M. Morell, Luca Fabris,
Romina Fiorotto, Mario Strazzabosco, The United States
P1142 NEXT GENERATION SEQUENCING ANALYSIS OF
CHOLESTATIC PATIENTS REVEALS HIGH IMPACT
VARIATION IN COMMON AND RARE CANDIDATE
GENES: DISSECTING THE GENETIC ARCHITECTURE OF
CHOLESTASIS
Roman Liebe, Alexander Christmann, Marcin Krawczyk*,
Piotr Milkiewicz, Frank Grünhage, Christoph Jüngst, Frank Lammert,
Germany
316 The International Liver Congress™ 2015 • ILC Programme
P1137 INTEGRATED EFFICACY SUMMARY FOR OBETICHOLIC
ACID IN SUBJECTS WITH PRIMARY BILIARY CIRRHOSIS
Pietro Invernizzi*, Rich Pencek, Tonya Marmon, Leigh MacConell,
David Shapiro, Italy
P1138 LONG-TERM OUTCOME OF PATIENTS WITH AUTOIMMUNE
HEPATITIS RECEIVING MYCOPHENOLATE MOFETIL
(MMF) AS FIRST LINE TREATMENT
Kalliopi Zachou*, Nikolaos Gatselis, Stella Gabeta, Asterios Saitis,
George Koukoulis, George N. Dalekos, Greece
P1139 TESTOSTERONE SUPPRESSES HEPATIC INFLAMMATION
BY THE DOWN-REGULATION OF IL-17, CXCL-9 AND CXCL-
10 IN A MOUSE MODEL OF EXPERIMENTAL CHOLANGITIS
Dorothee Schwinge*, Antonella Carambia, Alexander Quaas, Till Krech,
Claudia Wegscheid, Gisa Tiegs, Immo Prinz, Ansgar W. Lohse,
Johannes Herkel, Christoph Schramm, Germany
P1140 NGM282 DEMONSTRATES POTENT ANTIFIBROTIC
ACTIVITY IN A MOUSE MODEL OF SEVERE CHOLESTATIC
ePOSTERS FIBROSIS
Jian Luo*, Brian Ko, Carmen To, Lei Ling, Stephen Rossi, Alex DePaoli,
Hui Tian, The United States
P1141 POST-TRANSLATIONAL REGULATION OF POLYCYSTIN
2 (PC2) EXPRESSION AS A NOVEL MECHANISM OF
CHOLANGIOCYTE REACTION TO BILIARY DAMAGE AND
REPAIR
Carlo Spirli*, Ambra Villani, Carola M. Morell, Luca Fabris,
Romina Fiorotto, Mario Strazzabosco, The United States
P1142 NEXT GENERATION SEQUENCING ANALYSIS OF
CHOLESTATIC PATIENTS REVEALS HIGH IMPACT
VARIATION IN COMMON AND RARE CANDIDATE
GENES: DISSECTING THE GENETIC ARCHITECTURE OF
CHOLESTASIS
Roman Liebe, Alexander Christmann, Marcin Krawczyk*,
Piotr Milkiewicz, Frank Grünhage, Christoph Jüngst, Frank Lammert,
Germany
316 The International Liver Congress™ 2015 • ILC Programme
